-
-
-
-
-
-
-
CVRx Inc (CVRX) PT Raised to $13 at Cantor Fitzgerald
-
-
-
-
-
-
-
CMS proposes to maintain outpatient payment for CVRx Barostim procedure
-
-
-
-
-
-
-
Cantor Fitzgerald newsletter says Elutia best, Anteris worst performer
-
-
-
-
-
-
-
CVRx (CVRX) Reports Preliminary Fourth Quarter and Fiscal Year 2024 Financial Results and Issues Fiscal 2025 Guidance
-
-
-
-
-
-
-
CVRx (CVRX) announces new CPT Category I codes for Barostim
-
-
-
-
-
-
-
CVRx Inc (CVRX) PT Lowered to $12 at Lake Street Capital Markets
-
-
353,174 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

